2008 Press Releases
2007 Press Releases
2006 Press Releases
2005 Press Releases
Investor Events Calendar
May 12, 2008
Australian Taxation Office Class Ruling on Demerger
April 15, 2008
ChemGenex Reports Oral Bioavailability of Omacetaxine and Expands on Mechanism of Action
April 14, 2008
ChemGenex Confirms Planned NDA Rolling Submission for Omacetaxine Following Meeting with U.S. FDA
April 01, 2008
ChemGenex Investigators Present Data on Clinical Activity of Omacetaxine in Imatinib-Resistant Chronic Myeloid Leukemia Patients with the T315I Mutation at International Leukemia Conference
March 11, 2008
ChemGenex Launches Multi-Site Omacetaxine Clinical Trial in AML Patients
January 07, 2008
ChemGenex Appoints Dr. Julie Cherrington to Board of Directors
© 2005 ChemGenex Pharmaceuticals |
Terms of Use
